- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medison introduces new breast probe (it's nice and long)
Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an
Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an electronic broadband 5 to 10-MHz transducer with a center frequency of 7.5 MHz.
The probe can be used not only for breast cancer imaging, but also for thyroid and testicular cancer imaging, according to Dennis Wisher, director of ultrasound education. Since the probe is held in one position while it gathers 3-D volume data, it eliminates the need for sonographers to move a transducer over the patients skin, therefore reducing scan time and increasing accuracy, the company said. 3-D images generated by the probe can be rotated, and users can manipulate images with Medisons ultrasound software, which includes niche, transparent, trapezoid, surface rendering, and live 3-D modes.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
